NEM

Produit de santé naturel homologué au Canada

Autres noms: NEM Natural Eggshell Membrane, Natural Eggshell Membrane
Titulaire: WN Pharmaceuticals Ltd
NPN ou DIN-HM: 80114511
Statut: Licence active
Date de licence: 30 novembre 2021
Date de révision: Non renseignée
Forme: Capsule
Voie d'administration: Orale
Type de demande: Non traditionnelle

Si ce produit était vendu en France

Aucun point relevé par les règles que nous appliquons.

Une quantité quotidienne est calculée uniquement pour une posologie adulte orale explicite, exprimée par jour et dans une unité solide correspondant à la forme du produit. Les unités ambiguës, liquides, poudres et doses pédiatriques ne sont pas extrapolées. Une quantité non calculée n'est pas comparée aux limites de dose. Cette analyse ne constitue pas une autorisation de vente en France ni une évaluation de sécurité ou d'efficacité.

Composition

Ingrédient médicinal et source	Par unité posologique, selon la source	Par jour au plus, adulte
Membrane de coquille d'oeuf de poule partiellement hydrolysée Source : Gallus gallus - Coquille d'oeuf	500 mg	Non calculée

Ingrédients non médicinaux

Phosphate de calcium dibasique dihydraté, NA, Stéarate de magnésium, Silice, Eau purifiée

Doses recommandées au Canada

Population	Âge	Quantité par prise	Fréquence
Adultes	Non précisée	1 Capsule	1 jour

Usages autorisés au Canada

Texte fourni en anglais, faute de texte français disponible.

Increases joint flexibility. Helps provide relief from joint pain due to moderate intensity aerobic exercise (as quickly as 1 day). Clinically proven to provide relief from joint stiffness due to moderate intensity aerobic exercise (in as little as 5 days). Starts to reduce joint pain due to moderate intensity aerobic exercises in as little /as quickly as 1 day and joint stiffness in as little /as quickly as 5 days. Helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise. Helps to minimize discomfort due to moderate intensity aerobic exercise. Helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise.Helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise. Helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise in post-menopausal women. Helps to minimize discomfort due to moderate intensity aerobic exercise in post-menopausal women. Helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise in post-menopausal women. Helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise in post-menopausal women. Helps reduce joint pain and stiffness. Clinically proven to help reduce joint pain in 7-10 days. Helps to relieve joint pain and stiffness associated with osteoarthritis (of the knee). Helps reduce joint stiffness associated with osteoarthritis.Helps to relieve joint pain associated with osteoarthritis. Helps to relieve joint pain associated with osteoarthritis of the knee. Research-proven to help reduce joint pain in 7-10 days. Starts to help reduce pain and increase joint flexibility at 7 days. Helps relieve joint pain in 7-10 days. Helps to relieve pain associated with osteoarthritis of the knee. Helps to relieve/reduce joint pain associated with osteoarthritis.

Un usage autorisé au Canada n'est pas une allégation de santé autorisée dans l'Union européenne. Consultez le registre des allégations de santé.